Alnylam Pharmaceuticals (ALNY) Selling, General & Administrative (2009 - 2026)

Alnylam Pharmaceuticals (ALNY) Selling, General & Administrative (2009 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	SG&A (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	582.20 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	662.10 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	1.13 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	110.21 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	593.21 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	2,715.95
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	161.89 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	347.92 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	247.47 Mn
10	Roivant Sciences	26.16 Bn	26.85 Bn	1.16 Mn	165.53 Mn

Download Data